Nova Pneuma, Inc.

Nova Pneuma is a clinical-stage biotechnology company developing and commercializing therapies for serious acute medical conditions that require rapid treatment. It uses its proprietary Staccato One Breath Technology inhalation platform to deliver medicines systemically with rapid onset through a simple, non-invasive breath. Its portfolio includes ADASUVE, an approved treatment for acute agitation, and clinical and partnered pipeline programs addressing seizures, restless leg syndrome, cyclic vomiting syndrome, and Parkinson’s disease.